Losartan Related Compound B
CAS: 1006062-27-6
Rif. 3D-FL164204
2mg | Fuori produzione | ||
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione |
Informazioni sul prodotto
- [2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-yl]methyl Acetate
- 2-Butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]Methyl]-1H-iMidazole-5-Methanol 5-Acetate
- O-Acetyl Losartan
- [2-Butyl-4-chloro-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazol-5-yl]methyl acetate
- (1-((2′-(2H-Tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methyl acetate
- 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, 5-acetate
- (1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methyl acetate
Losartan Related Compound B is a nonpolar, synthetic organic compound that has the chemical formula CHClNO. It has been shown to inhibit nitrosamine formation in vitro and has a spectrum of activity against nitrosamines and other genotoxic impurities. Losartan Related Compound B is an innovative, analytical method for the detection of valsartan and its metabolites in pharmaceuticals. This substance fulfills pharmacological criteria as it inhibits angiotensin II-induced proliferation of vascular smooth muscle cells, vasoconstriction, and platelet aggregation.